Clinical Trials

Motor Improvement in Neurological Conditions (MINC): Feasibility of using a virtual dolphin to influence arm function and cognition in multiple sclerosis

Type of Study/Intervention

Interventional

Recruitment Status

Recruiting

Form of MS

Relapsing MS, Relapsing remitting MS, Secondary progressive MS, Primary progressive MS

Brief summary

The advent of technology that can enable immersive and engaging, high-dose practice, has led to new opportunities for restoring function in neurological patients. ECU’s Neurorehabilitation and Robotics (Edwards) Lab has acquired the Mindpod motion capture and gaming system, that enables fun exploration and practice using whole arm-hand in large movements to guide a dolphin to swim in a gaming environment. We test if this immersive digital gaming system in patients with MS, can safely and feasibly be conducted and can have positive effects on cognition, motor function, fatigue and quality of life.

Inclusion criteria

– At least 18 years of age
– Diagnosis of MS
– PDDS score of >0 and <=3 (< or =) (measure of your MS severity) - stable medical treatment at least 1 month prior to the intervention;

Exclusion criteria

– Already participating in exercise research
– Diagnosis of another neurological illness or musculoskeletal disorder different to MS;
– Diagnosis of a cardiovascular, respiratory, or metabolic illness or other conditions which may interfere with the study;
– Suffering a flare-up, relapse or hospitalization in the last month prior to commencement of the assessment protocol or – during the process of the therapeutic intervention;
– Pregnancy
– The presence of a noncorrected visual disorders

Anticipated start date

Already started.

Recruitment contacts

Mrs Kirsten van Rijn
Edith Cowan University
School of Medical and Health Sciences
270 Joondalup drive
Joondalup WA, 6027
Australia
Ph: +61 863046977
Email: o.vandergroen@ecu.edu.au

Further details

For further information, please check the ANZCTR website: ACTRN12622000281796.

Region

WA

Ethics approval

Yes

Last updated

09/05/2022

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search